Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia · Delayed Price · Currency is SAR 60.50
-0.05 (-0.08%)
Aug 13, 2026, 3:10 PM AST
TADAWUL:4016 Revenue
Middle East Pharmaceutical Industries Company had revenue of 136.48M SAR in the quarter ending June 30, 2026, with 16.00% growth. This brings the company's revenue in the last twelve months to 512.08M, up 18.52% year-over-year. In the year 2025, Middle East Pharmaceutical Industries Company had annual revenue of 460.48M with 16.87% growth.
Revenue (ttm)
512.08M
Revenue Growth
+18.52%
P/S Ratio
4.07
Revenue / Employee
700.52K
Employees
731
Market Cap
2.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 460.48M | 66.48M | 16.87% |
| Dec 31, 2024 | 394.00M | 55.56M | 16.42% |
| Dec 31, 2023 | 338.44M | 35.78M | 11.82% |
| Dec 31, 2022 | 302.66M | 15.44M | 5.38% |
| Dec 31, 2021 | 287.22M | -14.44M | -4.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.